We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
97 hedge funds and large institutions have $215M invested in Corcept Therapeutics in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 38 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
508% more call options, than puts
Call options by funds: $675K | Put options by funds: $111K
65% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 23
33% more capital invested
Capital invested by funds: $161M → $215M (+$53.5M)
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
1% less funds holding
Funds holding: 98 → 97 (-1)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
97
Holders Change
-1
Holders Change %
-1.02%
% of All Funds
2.55%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
11
Increased
38
Reduced
23
Closed
12
Calls
$675K
Puts
$111K
Net Calls
+$564K
Net Calls Change
+$113K
Top Buyers
| 1 |
ISL
Ingalls & Snyder LLC
New York
|
+$1.53M |
| 2 |
D.E. Shaw & Co
New York
|
+$693K |
| 3 |
GC
Globeflex Capital
San Diego,
California
|
+$685K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$563K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$543K |
